MedTrace Logo

Soy Protein Intake and the Metabolic Syndrome

NCT01694056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2013-01-04

No results posted yet for this study

Summary

Soy protein has a high biological value, and contains several potential health-related nutritional factors, i.e. its amino acids pattern, biological active peptides and non-protein compounds such as isoflavones. In the field of obesity and blood lipids soy protein is well-studied and appreciated; it improves circulating blood lipids and is associated with weight reduction. The effect of soy on insulin resistance, glucose homeostasis and the metabolic syndrome is less frequently studied. However, several molecular mechanisms of action of soy protein make it a promising approach.

Conditions

  • Metabolic Syndrome X

Interventions

OTHER

Soy protein diet

4 weeks high protein diet (20 en%) with 25gr of soy protein per day

OTHER

Control diet

4 weeks high mixed protein diet (20 en%)

Sponsors & Collaborators

  • Alpro Foundation

    collaborator OTHER

  • Wageningen University

    lead OTHER

Principal Investigators

  • Marco Mensink, PhD · Departement of Human Nutrition, Wageningen University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01694056 on ClinicalTrials.gov